Pharmaceutical Accountability Foundation

Pharmaceutical Accountability Foundation

Striving for equal access to medicines and medical technologies

Access to medicines is a human right

Access to medicines is an essential part of the human right to health. We believe the pharmaceutical industry must be held accountable when they limit needed access by raising prices to unsustainable levels in pursuit of unfair profits. We therefore investigate cases of pharmaceutical company abuse of market exclusivity rights to keep prices high at the expense of public health. We then work to inform the public, or take legal action if necessary. 

Issues

Why is medical technology so very expensive? There are many issues in the way. We currently incentivise innovation.

Solutions

There are several legal and policy solutions to stop misconduct, high prices, and limited access to medicines.

Cases

Examples of excessive pricing we have marked for investigation, or find illustrative of systemic challenges.

Recent News

Farma ter Verantwoording verwelkomt weigering van Zorginstituut Nederland om duur medicijn voor vergoeding aan te bevelen.

Medicijnkaper Lupin verhoogde de prijs van geneesmiddel honderdvoud.  Bergeijk, 14 januari 2021 - FTV verwelkomt het advies van het Zorginstituut Nederland om het door farmaceutisch bedrijf...

Historic victory in the case of health insurance company Menzis against the pharmaceutical company AstraZeneca

The Dutch District Court of The Hague has issued a historic and ground breaking judgement in the case of health insurance company Menzis against the...

Webinar: Covid-19: Future of pharmaceuticals.

Ellen 't Hoen - member of the advisory board talks in a webinar about the possible future of medicines and vaccines concerning Covid-19. Please watch...

Article about Orphan drugs and Drug hijackers

Chairman Wilbert Bannenberg, together with Ellen 't Hoen (member of the Advisory Board), published an article in the Dutch Journal of Medicine. In this article...